Free Trial

Elanco Animal Health (ELAN) Competitors

Elanco Animal Health logo
$14.40 -0.18 (-1.26%)
Closing price 07/29/2025 03:59 PM Eastern
Extended Trading
$14.31 -0.09 (-0.63%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ELAN vs. BNTX, SMMT, INSM, TEVA, GMAB, RDY, MRNA, QGEN, VTRS, and ASND

Should you be buying Elanco Animal Health stock or one of its competitors? The main competitors of Elanco Animal Health include BioNTech (BNTX), Summit Therapeutics (SMMT), Insmed (INSM), Teva Pharmaceutical Industries (TEVA), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Moderna (MRNA), Qiagen (QGEN), Viatris (VTRS), and Ascendis Pharma A/S (ASND). These companies are all part of the "pharmaceutical products" industry.

Elanco Animal Health vs. Its Competitors

Elanco Animal Health (NYSE:ELAN) and BioNTech (NASDAQ:BNTX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends.

Elanco Animal Health presently has a consensus price target of $16.17, suggesting a potential upside of 12.30%. BioNTech has a consensus price target of $136.58, suggesting a potential upside of 22.52%. Given BioNTech's higher probable upside, analysts plainly believe BioNTech is more favorable than Elanco Animal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elanco Animal Health
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.88
BioNTech
0 Sell rating(s)
4 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.83

Elanco Animal Health has a beta of 1.67, meaning that its share price is 67% more volatile than the S&P 500. Comparatively, BioNTech has a beta of 1.29, meaning that its share price is 29% more volatile than the S&P 500.

Elanco Animal Health has higher revenue and earnings than BioNTech. BioNTech is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elanco Animal Health$4.44B1.61$338M$0.7419.45
BioNTech$2.98B9.00-$719.92M-$3.40-32.79

97.5% of Elanco Animal Health shares are held by institutional investors. Comparatively, 15.5% of BioNTech shares are held by institutional investors. 0.9% of Elanco Animal Health shares are held by insiders. Comparatively, 19.2% of BioNTech shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Elanco Animal Health had 3 more articles in the media than BioNTech. MarketBeat recorded 14 mentions for Elanco Animal Health and 11 mentions for BioNTech. Elanco Animal Health's average media sentiment score of 1.04 beat BioNTech's score of 0.97 indicating that Elanco Animal Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elanco Animal Health
8 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BioNTech
7 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Elanco Animal Health has a net margin of 8.43% compared to BioNTech's net margin of -27.37%. Elanco Animal Health's return on equity of 7.54% beat BioNTech's return on equity.

Company Net Margins Return on Equity Return on Assets
Elanco Animal Health8.43% 7.54% 3.57%
BioNTech -27.37%-3.94%-3.41%

Summary

Elanco Animal Health beats BioNTech on 12 of the 16 factors compared between the two stocks.

Get Elanco Animal Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELAN vs. The Competition

MetricElanco Animal HealthMED IndustryMedical SectorNYSE Exchange
Market Cap$7.24B$3.77B$5.70B$21.03B
Dividend YieldN/A1.34%4.71%3.60%
P/E Ratio19.4534.8928.1927.92
Price / Sales1.61120.19391.9468.05
Price / Cash6.4722.0636.3223.29
Price / Book1.174.388.284.54
Net Income$338M$189.47M$3.25B$993.24M
7 Day Performance-4.12%-2.50%-2.00%-1.51%
1 Month Performance0.74%-3.15%8.67%3.16%
1 Year Performance11.60%-2.89%34.65%9.14%

Elanco Animal Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELAN
Elanco Animal Health
3.2591 of 5 stars
$14.40
-1.3%
$16.17
+12.3%
+11.4%$7.24B$4.44B19.459,000
BNTX
BioNTech
1.4636 of 5 stars
$108.91
-1.0%
$136.58
+25.4%
+28.7%$26.18B$2.98B-32.036,772Upcoming Earnings
SMMT
Summit Therapeutics
2.9907 of 5 stars
$26.34
+0.5%
$34.67
+31.6%
+148.1%$19.56B$700K-77.47110Upcoming Earnings
INSM
Insmed
3.9281 of 5 stars
$102.78
+0.2%
$108.47
+5.5%
+40.8%$19.50B$363.71M-17.271,271Positive News
Upcoming Earnings
TEVA
Teva Pharmaceutical Industries
4.0949 of 5 stars
$16.30
+1.5%
$24.71
+51.7%
-1.0%$18.69B$16.54B-14.1736,830News Coverage
Positive News
Gap Up
GMAB
Genmab A/S
4.0342 of 5 stars
$21.69
-0.9%
$37.80
+74.3%
-20.6%$13.92B$3.12B12.322,682Positive News
Analyst Upgrade
RDY
Dr. Reddy's Laboratories
2.6717 of 5 stars
$14.57
+0.6%
$16.95
+16.4%
-10.0%$12.16B$3.81B22.0727,811Earnings Report
MRNA
Moderna
4.3435 of 5 stars
$30.97
-0.9%
$46.61
+50.5%
-73.3%$11.98B$3.24B-3.555,800Upcoming Earnings
QGEN
Qiagen
3.6468 of 5 stars
$48.06
-0.6%
$49.40
+2.8%
+18.7%$10.68B$1.98B120.495,765Upcoming Earnings
VTRS
Viatris
2.6216 of 5 stars
$8.90
+0.2%
$10.40
+16.9%
-22.8%$10.45B$14.74B-2.8132,000
ASND
Ascendis Pharma A/S
3.3866 of 5 stars
$168.02
-1.1%
$223.07
+32.8%
+21.7%$10.39B$368.70M-26.751,017Analyst Forecast

Related Companies and Tools


This page (NYSE:ELAN) was last updated on 7/30/2025 by MarketBeat.com Staff
From Our Partners